Metraipolis › archive › dc_ba4e32eef7aa

Mapping the genetic-transcriptional landscape of thyroid irAEs in sintilimab therapy: toward biomarker-guided immunotoxicity prediction — Europe PMC PMID:41221294

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41221294
DOI: 10.3389/fimmu.2025.1671594
License (as archived): solo-consultazione
Archived: 2026-11-09T00:55:26.551Z
SHA-256 of the archived text: eb5e6a71df457a3995e1535b15e939eaba2c328f6054acf30bae50585500a3d6
Stable URL of this page: https://metraipolis.com/documento/dc_ba4e32eef7aa

How to cite

Mapping the genetic-transcriptional landscape of thyroid irAEs in sintilimab therapy: toward biomarker-guided immunotoxicity prediction — Europe PMC PMID:41221294 — Europe PMC (en), https://europepmc.org/article/MED/41221294 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba4e32eef7aa (Metraipolis archive dc_ba4e32eef7aa, sha256 eb5e6a71df457a3995e1535b15e939eaba2c328f6054acf30bae50585500a3d6)

BibTeX

@misc{dcba4e32eef7aa,
  title = {Mapping the genetic-transcriptional landscape of thyroid irAEs in sintilimab therapy: toward biomarker-guided immunotoxicity prediction — Europe PMC PMID:41221294},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41221294},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba4e32eef7aa; sha256 eb5e6a71df457a3995e1535b15e939eaba2c328f6054acf30bae50585500a3d6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41221294. Agents can read the archived copy with the MCP tool read_document.